The 2023 Fall Clinical Dermatology conference featured research on treatments for alopecia areata, acne, psoriasis, atopic dermatitis, and vitiligo. The Fall Clinical Dermatology conference presented ...

In September 2024, BioWorld recorded 252 clinical trial updates, up from 92 in August, due in part to news from the European Society for Cardiology Congress, the IASCLC World Conference on Lung Cancer ...

Cabaletta Bio, Inc., a clinical-stage biotechnology company focused on targeted cell therapies for autoimmune diseases, announced that updated clinical data on its investigational therapy, ...

The Conference Forum announced today the launch of the 9th annual CRAACO®: Clinical Research as a Care Option conference, taking place September 16, 2024 at the Loews Philadelphia Hotel in ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (Nasdaq: BIIB) today announced new interim Phase 2 results from NURTURE, the ongoing open-label, single-arm study evaluating the efficacy and safety of ...

Preclinical in vitro studies demonstrated >80% reduction in protease activity, including complete inhibition of TACE and collagenase — key factors in non-healing chronic wounds revyve® data featured ...

The increasing incidence of cancer in sub-Saharan Africa (SSA) has highlighted gaps in access to quality cancer care and subsequent poor outcomes. Two of the factors responsible for this disparity are ...

Mumbai: Amidst the ever-changing and constantly evolving landscape of pharmaceuticals, and medical devices, clinical research has become an indispensable aspect in advancing medical efficiency.

Dubai, United Arab Emirates--(Newsfile Corp. - October 31, 2025) - International Modern Hospital (IMH) successfully hosted its 1st Clinical Conference 2025, themed "Mechanical Ventilation: A ...

Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve® over 6-12 weeks Preclinical in vitro ...